| CD8+ T-cell responses to different HIV proteins have discordant associations with viral load P Kiepiela, K Ngumbela, C Thobakgale, D Ramduth, I Honeyborne, ... Nature medicine 13 (1), 46-53, 2007 | 1251 | 2007 |
| HIV evolution: CTL escape mutation and reversion after transmission AJ Leslie, KJ Pfafferott, P Chetty, R Draenert, MM Addo, M Feeney, ... Nature medicine 10 (3), 282-289, 2004 | 1069 | 2004 |
| Adaptation of HIV-1 to human leukocyte antigen class I Y Kawashima, K Pfafferott, J Frater, P Matthews, R Payne, M Addo, ... Nature 458 (7238), 641-645, 2009 | 564 | 2009 |
| Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1 J Martinez-Picado, JG Prado, EE Fry, K Pfafferott, A Leslie, S Chetty, ... Journal of virology 80 (7), 3617-3623, 2006 | 557 | 2006 |
| Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection R Draenert, S Le Gall, KJ Pfafferott, AJ Leslie, P Chetty, C Brander, ... The Journal of experimental medicine 199 (7), 905-915, 2004 | 390 | 2004 |
| Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B* 5703-restricted Gag epitope in chronic human … H Crawford, JG Prado, A Leslie, S Hué, I Honeyborne, S Reddy, ... Journal of virology 81 (15), 8346-8351, 2007 | 271 | 2007 |
| HIV-1 infection is characterized by profound depletion of CD161+ Th17 cells and gradual decline in regulatory T cells A Prendergast, JG Prado, YH Kang, F Chen, LA Riddell, G Luzzi, ... Aids 24 (4), 491-502, 2010 | 238 | 2010 |
| Evolution of HLA-B* 5703 HIV-1 escape mutations in HLA-B* 5703–positive individuals and their transmission recipients H Crawford, W Lumm, A Leslie, M Schaefer, D Boeras, JG Prado, J Tang, ... Journal of Experimental Medicine 206 (4), 909-921, 2009 | 207 | 2009 |
| Restriction factors: from intrinsic viral restriction to shaping cellular immunity against HIV-1 M Colomer-Lluch, A Ruiz, A Moris, JG Prado Frontiers in immunology 9, 2876, 2018 | 187 | 2018 |
| Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity JG Prado, T Wrin, J Beauchaine, L Ruiz, CJ Petropoulos, SDW Frost, ... Aids 16 (7), 1009-1017, 2002 | 141 | 2002 |
| Selection of drug-resistant HIV-1 mutants in response to repeated structured treatment interruptions J Martinez-Picado, K Morales-Lopetegi, T Wrin, JG Prado, SDW Frost, ... Aids 16 (6), 895-899, 2002 | 140 | 2002 |
| Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia D Sánchez-Martínez, ML Baroni, F Gutierrez-Agüera, H Roca-Ho, ... Blood, The Journal of the American Society of Hematology 133 (21), 2291-2304, 2019 | 122 | 2019 |
| Resident memory T cells are a cellular reservoir for HIV in the cervical mucosa J Cantero-Pérez, J Grau-Expósito, C Serra-Peinado, DA Rosero, ... Nature communications 10 (1), 4739, 2019 | 121 | 2019 |
| Sialyllactose in viral membrane gangliosides is a novel molecular recognition pattern for mature dendritic cell capture of HIV-1 N Izquierdo-Useros, M Lorizate, FX Contreras, MT Rodriguez-Plata, ... PLoS biology 10 (4), e1001315, 2012 | 117 | 2012 |
| Efficacious Early Antiviral Activity of HIV Gag- and Pol-Specific HLA-B*2705-Restricted CD8+ T Cells RP Payne, H Kløverpris, JB Sacha, Z Brumme, C Brumme, S Buus, ... Journal of virology 84 (20), 10543-10557, 2010 | 111 | 2010 |
| Role of structured treatment interruption before a 5-drug salvage antiretroviral regimen: the Retrogene Study L Ruiz, E Ribera, A Bonjoch, J Romeu, J Martinez-Picado, R Paredes, ... The Journal of infectious diseases 188 (7), 977-985, 2003 | 104 | 2003 |
| Assessment of the feasibility and safety of durvalumab for treatment of solid tumors in patients with HIV-1 infection: the phase 2 DURVAST study M Gonzalez-Cao, T Morán, J Dalmau, J Garcia-Corbacho, JWP Bracht, ... JAMA oncology 6 (7), 1063-1067, 2020 | 99 | 2020 |
| Factors leading to the loss of natural elite control of HIV-1 infection M Pernas, L Tarancon-Diez, E Rodriguez-Gallego, J Gomez, JG Prado, ... Journal of virology 92 (5), 10.1128/jvi. 01805-17, 2018 | 87 | 2018 |
| CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir R Badia, E Ballana, M Castellví, E García-Vidal, M Pujantell, B Clotet, ... Nature communications 9 (1), 2739, 2018 | 81 | 2018 |
| Discordant impact of HLA on viral replicative capacity and disease progression in pediatric and adult HIV infection E Adland, P Paioni, C Thobakgale, L Laker, L Mori, M Muenchhoff, ... PLoS pathogens 11 (6), e1004954, 2015 | 68 | 2015 |
